Navigation Links
AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
Date:8/29/2012

livery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps.  AcelRx has two additional product candidates which have completed Phase 2 clinical development: ARX-02 for the treatment of cancer breakthrough pain, and ARX-03 for mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.   AcelRx plans to initiate a Phase 2 study, pending protocol approval, for a fourth product candidate, ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from USAMRMC.  For additional information about AcelRx's clinical programs please visit www.acelrx.com.

Forward Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to AcelRx Pharmaceuticals' patent portfolio, including the useful life of its U.S. patents and the European patent, the continued expansion of its patent protection, market exclusivity, its ability to protect its proprietary technology, the scope of patent protection, and issued and planned or anticipated future clinical development of AcelRx Pharmaceuticals' product candidates, including the execution of the Phase 3 clinical studies for ARX-01,  the initiation of Phase 2 clinical trial for ARX-04, and the therapeutic potential of AcelRx Pharmaceuticals' product candidates.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties.  AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the success, cost and timing of AcelRx Pharmaceuticals' product development activities and c
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  4WEB Medical announces the ... foot and ankle osteotomy implants on the market ... Society annual meeting in Chicago . ... of a surgeon,s osteotomy needs with 74 size options included ... had smaller offerings of only 15 to 18 implant sizes, ...
(Date:9/19/2014)... NORWALK, Conn. , Sept. 19, 2014 ... , a leading online community to help oncologists ... newest information available regarding the use of targeted therapies ... blood cancer research and treatment.  Every ... as a way to raise awareness about blood cancers—helping ...
(Date:9/19/2014)... 19, 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ... received and approved all parts required to build ... begun to manufacture the new PCT-based instrument system.  ... ready for shipment by mid-October and that additional ... a rate of about one per week thereafter.  ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
(Date:9/19/2014)... More states are passing legislation permitting or requiring schools ... child having a severe allergic reaction. Epinephrine auto-injectors ... that can lead to throat swelling, breathing difficulties, a ... In people with severe allergies to certain foods, ... certain drugs, anaphylaxis can occur within moments of exposure ...
(Date:9/19/2014)... Medical College of Wisconsin (MCW) scientists has identified a new ... mice and in humans. The findings are published in the ... Leah Solberg Woods, Ph.D., associate professor of pediatrics at MCW ... Institute, led the study and is the corresponding author of ... gene called Tpcn2 in which a variant was associated with ...
(Date:9/19/2014)... Wellesley, MA (PRWEB) September 19, 2014 ... ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS , the global ... to nearly $13.9 billion by 2018, with a five-year ... over-the-counter (OTC) segment is growing at a steady 3.8% ... is often presenting lower sales, coupled with the incidence ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... presale tickets for her 2015 “Honeymoon” Tour. ... code ARIANA-2015 for additional savings at the checkout. , Ariana ... City, MO (Independence Event Center) , Feb. 28, 2015: Milwaukee, ... Paul, MN (Xcel Energy Center) , March 03, 2015: Chicago, ...
(Date:9/19/2014)... material graphene has been used to detect molecules that ... The biosensor has been shown to be more than ... use, and was able to provide results in a ... rapid, point-of-care diagnostic tool for patients. , The biosensor ... journal 2D Materials . , To develop a ...
Breaking Medicine News(10 mins):Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 2Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 3Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:Graphene sensor tracks down cancer biomarkers 2
... Mich. Doctors are increasingly using a convenient blood glucose ... the University of Michigan,s C.S. Mott Children,s Hospital shows it,s ... The hemoglobin A1c test has become the preferred way ... diabetes but show no symptoms. The simple test measures longer-term ...
... for seniors to remain living in their homes. The ... that more than one-third of caregivers had difficulty reading ... errors when sorting medications into pillboxes. The study ... Internal Medicine . It has been published online. ...
... A U.S. law protects drug makers from lawsuits filed for ... ruled Tuesday. The court, in a six-to-two vote, decided ... problems were caused by a diphtheria, tetanus and pertussis vaccine ... sued the vaccine maker, Wyeth, which was acquired by Pfizer ...
... Three American College of Radiology commission and committee chairs ... Chancellors will outline strategies for transforming computed tomography (CT) ... at a Feb. 24, 25 event sponsored by the ... on Management of Radiation Dose in Computerized Tomography ...
... (HealthDay News) -- Concentrations of bisphenol A -- a chemical ... Canadians than Americans, a new study has found. Bisphenol ... products, from food packaging to electronic equipment and cars. Studies ... animals and this has raised concerns that it may have ...
... Feb. 22 (HealthDay News) -- Despite suggestions that hard ... known as atopic eczema, a new British study has ... sufferers. "Although the outcome is disappointing in terms ... outcome of the trial is very clear," the study,s ...
Cached Medicine News:Health News:Convenient blood test not as effective for diagnosing diabetes in children 2Health News:Struggling to follow doctor's orders 2Health News:Supreme Court Rejects Vaccine-Safety Lawsuit 2Health News:ACR commission and committee chairs and former board chair to present at NIH Radiation Dose Summit 2Health News:Plastics Chemical Affects U.S. More Than Canada: Study 2Health News:Softening Water Does Not Seem to Ease Eczema 2
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, high viscosity bone cement for digital use with an average setting time of approx. 6-8 Min., 41.6g of powder and 14.4g of liquid....
... new thinking to address common problems associated ... mm diameter outer arthroscope sheath, the shorter, ... Videoscope has superior access and mobility in ... and especially in the elbow and ankle. ...
... The OMEGA 180 features a wide ... One-Step Small and Variable Pupil Control (U.S. ... pupil sizes down to 1.2mm. Heine's unique ... illumination, making learning BIO easier, and simplifying ...
Medicine Products: